Effect of targeted temperature management on cerebrospinal fluid IL-6 in patients with severe craniocerebral injury

Corresponding author: zhanglei, 16981335@qq.com

DOI: 10.12201/bmr.202501.00079

•  

  Abstract: Objective To investigate the effect of targeted temperature management on Cerebrospinal fluid interleukin 6 and prognosis in patients with severe traumatic brain injury. Methods Forty patients with severe traumatic brain injury were randomly divided into two groups (normothermia group and hypothermic group, 20 cases in each group) , In normothermia group, the core temperature was controlled at 36-37.3℃，in hypothermic group, the core temperature was controlled at 35-35.9℃ for 7 days. The CSF IL-6, ICP, GCS score, Apache II score before and after treatment, the incidence of complications and GOS score after 3 months were observed. Results Compared with the normothermia group, the CSF IL-6 and ICP in the hypothermia group decreased more rapidly on the 7th day, GCS score was higher and APACHE II score was lower after treatment, GOS had a higher good prognosis rate, there were significant differences in the above indexes (P<0.05).There was no significant difference in the incidence of complications between the two groups (P>0.05). Conclusion Mild hypothermia (core temperature 35-35.9℃) can reduce the level of cerebrospinal fluid IL-6, reduce the inflammation and ICP, no increase the incidence of complications, improve the clinical prognosis in patients with severe traumatic brain injury.

  Key words: Targeted temperature management；Severe craniocerebral injury；Cerebrospinal fluid interleukin 6；Prognosis

  Submit time: 26 January 2025

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• The diagnostic value of neutrophil CD64 index, CRP, IL-6, and PCT levels in viral and bacterial respiratory infections. 2024. doi: 10.12201/bmr.202412.00064

  李泽明, zhoujianyong, chentingting, wangcheng, liuzhenkun, qimei, lvjiling. Exploring the mechanism of Xiaochaihu Decoction in treating cough variant asthma (CVA) based on network pharmacology and animal experiments. 2025. doi: 10.12201/bmr.202510.00009

  Chen Lili. Study on the immune regulatory mechanism of ω－3PUFA in premature infants with brain injury. 2024. doi: 10.12201/bmr.202408.00011

  Yaoqian. The effect of polydatin on myocardial injury in rats with doxorubicin induced dilated cardiomyopathy by regulating the Shh/Gli1 signaling pathway. 2025. doi: 10.12201/bmr.202506.00013

  Wang Hufeng, Zhao Yang. Research trends of chronic diseases in China in the past 6 years before and after the implementation of Healthy China Strategy: Transition from treatment to management. 2023. doi: 10.12201/bmr.202306.00003

  TANG Kan-kai, LIU Feng-qi, CHEN Zhi-dong. Effects of α7 nicotinic acetylcholine receptor agonist on intestinal injury and mitochondrial autophagy in sepsis mice. 2024. doi: 10.12201/bmr.202410.00066

  Liu Jianyi, Liu Yan, Gao Yunchun, Jin Ling. Risk factors and prognostic analysis of early myocardial injury after acute carbon monoxide poisoning. 2025. doi: 10.12201/bmr.202504.00060

  The impact of evidence-based nutritional care on disease outcomes in patients with severe heart failure. 2025. doi: 10.12201/bmr.202503.00018

  LiuChengxin, ZhengAihua. Based on The Theory of Lung and Intestine Treatment, The Treatment Experience of Shengxue Tongbian Granules for Acute Lung Injury of Sepsis was explored*. 2025. doi: 10.12201/bmr.202509.00041

  Lu jianliang, Feng yuan, Lu yanling. Analysis of clinical characteristics of severe mycoplasma pneumoniae pneumonia in children. 2025. doi: 10.12201/bmr.202505.00038

• ID	Submit time	Number	Download
  1	2024-12-25	10.12201/bmr.202501.00079V1	Download

• Public  Anonymous  To author only Submit Comments